| Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives F Seker-Polat, N Pinarbasi Degirmenci, I Solaroglu, T Bagci-Onder Cancers 14 (2), 443, 2022 | 94 | 2022 |
| Identification of SERPINE1 as a regulator of glioblastoma cell dispersal with transcriptome profiling F Seker, A Cingoz, I Sur-Erdem, N Erguder, A Erkent, F Uyulur, ... Cancers 11 (11), 1651, 2019 | 61 | 2019 |
| Gelatin methacryloyl hydrogels in the absence of a crosslinker as 3D glioblastoma multiforme (GBM)‐mimetic microenvironment P Erkoc, F Seker, T Bagci‐Onder, S Kizilel Macromolecular bioscience 18 (3), 1700369, 2018 | 50 | 2018 |
| The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme E Kaya-Aksoy, A Cingoz, F Senbabaoglu, F Seker, I Sur-Erdem, ... Cell death discovery 5 (1), 64, 2019 | 42 | 2019 |
| The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma E Ozyerli-Goknar, I Sur-Erdem, F Seker, A Cingöz, A Kayabolen, ... Cell Death & Disease 10 (12), 894, 2019 | 26 | 2019 |
| Parameters influencing gene delivery efficiency of PEGylated chitosan nanoparticles: experimental and modeling approach NO Dogan, U Bozuyuk, P Erkoc, AC Karacakol, A Cingoz, F Seker-Polat, ... Advanced NanoBiomed Research 2 (1), 2100033, 2022 | 17 | 2022 |
| TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway I Sur-Erdem, K Muslu, N Pınarbası, M Altunbek, F Seker-Polat, A Cingöz, ... Neurological Research 42 (12), 1061-1069, 2020 | 16 | 2020 |
| Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization A Cingöz, E Ozyerli-Goknar, T Morova, F Seker-Polat, M Esai Selvan, ... Oncogene 40 (18), 3201-3216, 2021 | 13 | 2021 |
| Engineered MED12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization K Buyukcelebi, X Chen, F Abdula, H Elkafas, AJ Duval, H Ozturk, ... Nature communications 14 (1), 4057, 2023 | 10 | 2023 |
| Depletion of lamins B1 and B2 promotes chromatin mobility and induces differential gene expression by a mesoscale-motion-dependent mechanism EM Pujadas Liwag, X Wei, N Acosta, LM Carter, J Yang, LM Almassalha, ... Genome biology 25 (1), 77, 2024 | 4 | 2024 |
| Depletion of lamins B1 and B2 alters chromatin mobility and induces differential gene expression by a mesoscale-motion dependent mechanism EM Pujadas, X Wei, N Acosta, L Carter, J Yang, L Almassalha, ... bioRxiv, 2023.06. 26.546573, 2023 | 4 | 2023 |
| Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma F Senbabaoglu, AC Aksu, A Cingoz, F Seker-Polat, E Borklu-Yucel, ... Frontiers in Neuroscience 14, 578316, 2020 | 3 | 2020 |
| Integrating leiomyoma genetics, epigenomics, and single-cell transcriptomics reveals causal genetic variants, genes, and cell types K Buyukcelebi, AJ Duval, F Abdula, H Elkafas, F Seker-Polat, M Adli Nature communications 15 (1), 1169, 2024 | 2 | 2024 |
| Combined inhibition of KDM6A/B and HDACs exacerbates integrated stress response and mediates therapeutic effects in IDH1-mutant glioma A Kayabolen, GN Sahin, F Seker-Polat, A Cingoz, B Isik, S Acar, ... bioRxiv, 2020 | 2 | 2020 |
| Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic) 2-like protein (ASH2L) as a regulator of glioblastoma cell survival E Ozyerli-Goknar, EY Kala, AC Aksu, I Bulut, A Cingöz, S Nizamuddin, ... Cell Communication and Signaling 21 (1), 328, 2023 | 1 | 2023 |
| Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization A Cingöz, E Ozyerli-Goknar, T Morova, F Seker-Polat, ME Selvan, ... Oncogene 43 (34), 2612, 2024 | | 2024 |
| Erratum to: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization (Oncogene,(2021), 40, 18,(3201-3216 … A Cingöz, E Ozyerli-Goknar, T Morova, F Seker-Polat, ME Selvan, ... Oncogene, 2024 | | 2024 |
| Integrative analysis of uterine leiomyoma genetics, epigenomics, and single-cell transcriptomics reveals causal genetic variants, gene targets, and cell types K Buyukcelebi, F Seker-Polat, F Abdula, M Kinali, M Adli | | 2023 |
| Engineered MED12 mutations drive uterine fibroid-like transcriptional and metabolic programs by altering the 3D genome compartmentalization K Buyukcelebi, X Chen, F Abdula, A Duval, H Ozturk, F Seker-Polat, Q Jin, ... Research square, 2023 | | 2023 |
| Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survival E Ozyerli-Goknar, EY Kala, AC Aksu, I Bulut, A Cingöz, S Nizamuddin, ... bioRxiv, 2022.08. 17.504245, 2022 | | 2022 |
